The Colorado Department of Public Health & Environment (CDPHE) just released a report focused on examining THC concentrations in Colorado and the implications to public health. Contained in this report is a primer on marijuana in Colorado and the evolution of THC concentration levels of products available in the open marketplace. Also found in the […]
Marijuana is one of the most common illicit drugs used by patients with schizophrenia. Recent research into marijuana’s adverse role for people dealing with psychosis and schizophrenia is concerning. The author, Dr. Brian Miller (MD, PhD, MPH), has complied a series of research studies and their key findings that outline the numerous risks associated with the […]
Marijuana still remains of concern when addressing youth use, access and health impacts. To help bridge that gap the Drug-Free Communities (DFC) program, a federally funded drug prevention and education program since 1997, focuses on reducing substance use in both youths and adults. The DFC program just released their annual report and cited these key […]
With the passage of the Agriculture Improvement Act of 2018, also known as the “2018 Farm Bill”, hemp (part of the Cannabis Sativa L. plant) became a legal agricultural commodity. The caveat to this designation is that hemp, by definition, is to have a potency level of Delta-9 Tetrahydrocannabinol (THC) of not greater than .3 percent. […]
The Community Anti-Drug Coalitions of America (CADCA) has just issued the twelfth edition in their ongoing educational “Practical Theorist” series. The “Practical Theorist 12” focuses on the current state of marijuana in America. This document provides the reader a wide range of information on a variety of topics with findings based in current research. The impressive […]
The Financial Crimes Enforcement Network (FinCEN) just issued guidance to financial institutions doing business with hemp-related businesses. “Hemp” is a part of the Cannabis Sativa L. family that contains no more than .3 percent potency level of Delta-9 tetrahydrocannabinol (THC). Hemp was removed from the controlled substances list and reclassified as an agricultural commodity as […]
Released in the June 22, 2020 version of JAMA Internal Medicine (doi:10.1001/jamainternmed.2020.1769 ) comes research from Kamer (et.al) that examines the fatal motor vehicle collision rates in the original four states that legalized marijuana for “recreational” use. Three of the four states did record increases in their fatal collision rates post legalization. The authors did report […]
The June 10, 2020 edition of the JAMA Psychiatry released emerging research from the University of Colorado (Boulder) into the effects of high and low potency THC with respect for both intoxication and impairment. This study looked at 121 participants who were dosed with raw marijuana flower (THC potency of 16 or 34 percent) or […]
The Injury Prevention Center (IPC), at the prestigious University of Michigan, is one of only nine such research centers in the United States that is funded by the Centers for Disease Control (CDC). The focus of the IPC is on the prevention and reduction of injuries by means of a multidisciplinary approach that includes both […]
When purchasing retail marijuana-based products, the consumer should be aware of the potential impacts of that choice, both financially and possibly to their own health. From reported adverse health effects stemming from use of high potency products to unsupported claims of medical benefits, this bulletin gives a broad overview of some of the issues associated […]
